Logo-bi
Original Research
Ali Mesgari-Shadi, Mohammad Hossein Sarrafzadeh*
Bioimpacts. 2017;7(3): 199-206. doi: 10.15171/bi.2017.23
PMCID: PMC5684511     PMID: 29159147     Scopus ID: 85032034154    
Short Communication
Smritee Singh, Priya Mishra, Ivneet Banga, Avanish S Parmar, Prem Prakash Tripathi, Sonu Gandhi*
Bioimpacts. 2018;8(1): 53-58. doi: 10.15171/bi.2018.07
PMCID: PMC5915709     PMID: 29713602     Scopus ID: 85044261366    
Original Research
Parisa Ebrahimisadr* ORCID, Zahra Bakhshandeh, Hamidreza Majidiani
BioImpacts. 2021;11(2): 129-133. doi: 10.34172/bi.2021.20
PMCID: PMC8022230     PMID: 33842283     Scopus ID: 85106638656    
One of the major complications in thalassemia patients is alloimmunization, The best way to manage alloimmunized patients is to identify the type of alloantibodies with antibody screening and identification tests and blood transfusion of the negative antigen.
Original Research
Shahram Parvaneh ORCID, Fatemeh Khademi, Gisya Abdi, Abdolhamid Alizadeh, Ali Mostafaie* ORCID
BioImpacts. 2021;11(4): 237-244. doi: 10.34172/bi.2021.34
PMCID: PMC8494260     PMID: 34631485     Scopus ID: 85113738808    
We could fabricate stable and high active Fe3O4@SiO2/NH2, and antibodies were conjugated to the surface of them from the Fc region, causing a higher binding capacity with no alteration or inhibition in the paratope area of the antibody molecule.
Schematic of the microfluidic device, top view and cross section of the middle part of the microfluidic device, tumor cell labeled with the functionalized antibodies with the Fe3O4 PMNPs, surface functionalization of the Si nanowires, SEM images of the middle part of the Si substrate with well-aligned SiNWs, SEM images of the tilted view of cancer cells trapped on the nanowires substrate microfluidic channel.
Original Article
Marina Vladimirovna Silkina ORCID, Alena Sergeevna Kartseva ORCID, Alena Konstantinovna Riabko ORCID, Mariia Aleksandrovna Makarova ORCID, Metkhun Madibronovich Rogozin, Yana Olegovna Romanenko ORCID, Igor Georgievich Shemyakin ORCID, Ivan Alekseevich Dyatlov ORCID, Victoria Valerievna Firstova* ORCID
Bioimpacts. 2024;14(4): 27680. doi: 10.34172/bi.2023.27680
PMCID: PMC11298023     PMID: 39104622     Scopus ID: 85198967589    


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge